CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 71 filers reported holding CULLINAN ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,279 | +323.0% | 15,390 | +402.9% | 0.00% | +300.0% |
| Q2 2023 | $32,926 | +143056.5% | 3,060 | +39.0% | 0.00% | 0.0% |
| Q1 2023 | $23 | +91.7% | 2,202 | +83.5% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 1,200 | -29.2% | 0.00% | – |
| Q3 2022 | $22,000 | +15.8% | 1,694 | +15.1% | 0.00% | – |
| Q2 2022 | $19,000 | -65.5% | 1,472 | -72.3% | 0.00% | -100.0% |
| Q1 2022 | $55,000 | -38.9% | 5,314 | -9.1% | 0.00% | -50.0% |
| Q4 2021 | $90,000 | +429.4% | 5,846 | +691.1% | 0.00% | – |
| Q3 2021 | $17,000 | -15.0% | 739 | -3.4% | 0.00% | -100.0% |
| Q2 2021 | $20,000 | -41.2% | 765 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $34,000 | – | 820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |